Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin dosing in severe nephrotic syndrome
NCT04558892Phase 3Terminated
- Sponsor
- Military Institute of Medicine – National Research Institute
- Start
- Oct 2015
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Military Institute of Medicine – National Research Institute. Started Oct 2015; status: terminated.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04558892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558892.